Arix Bioscience Plc Publication of Annual Report & Notice of AGM (9948K)

TIDMARIX

RNS Number : 9948K

Arix Bioscience Plc

12 May 2022

12 May 2022

ARIX BIOSCIENCE PLC (the "Company")

Publication of Annual Report and Notice of Annual General Meeting

Further to the Company's 2021 Annual Financial Results announcement issued on 5 May 2022, Arix Bioscience Plc, announces that it has today published the Annual Report and Accounts (the "Annual Report") for the financial year ended 31 December 2021 together with its Notice of 2022 Annual General Meeting (the "AGM").

The Company hereby confirms that its Annual General Meeting will be held on Tuesday 7 June 2022 at 11:00 (BST) at the offices of Brown Rudnick LLP, 8 Clifford Street, London, W1S 2LQ, United Kingdom.

The following documents have today been posted or otherwise made available to shareholders by the Company:

   1.     Form of Proxy 
   2.     Notice of 2022 Annual General Meeting 
   3.    Annual Report and Accounts 2021 

The Form of Proxy is publicly available on the Company's website:

https://arixbioscience.com/investor-relations/document-library

The Annual Report and Notice of AGM is also publicly available on the Company's website:

https://arixbioscience.com/investor-relations/document-library

Copies of the above documents have been submitted to the UK National Storage Mechanism. The documents will therefore shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:

Arix Bioscience Plc

Duke Street House,

50 Duke Street,

London,

W1K 6JL,

United Kingdom

Enquiries:

   Email:     [e-mail] 
   LEI:          213800OVT3AHQCXNIX43 

Registrar and Receiving Agent: Equiniti Limited - 0371 384 2030 or [phone]

Company Secretary: Kin Company Secretarial Limited - [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOASFLFLSEESEDI

(END) Dow Jones Newswires

May 12, 2022 02:02 ET (06:02 GMT)